Edgestream Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-898
| Closed | -$311K | – | 851 |
|
|
2024
Q1 | $311K | Sell |
898
-8,134
| -90% | -$2.81M | 0.02% | 719 |
|
|
2023
Q4 | $2.92M | Buy |
9,032
+3,754
| +71% | +$1.21M | 0.21% | 144 |
|
|
2023
Q3 | $1.89M | Buy |
+5,278
| New | +$1.89M | 0.15% | 209 |
|
|
2023
Q2 | – | Sell |
-762
| Closed | -$365K | – | 723 |
|
|
2023
Q1 | $365K | Buy |
+762
| New | +$365K | 0.04% | 447 |
|
|
2022
Q4 | – | Sell |
-8,660
| Closed | -$3.61M | – | 509 |
|
|
2022
Q3 | $3.61M | Buy |
8,660
+6,857
| +380% | +$2.86M | 0.28% | 129 |
|
|
2022
Q2 | $892K | Buy |
+1,803
| New | +$892K | 0.07% | 343 |
|
|
2021
Q3 | – | Sell |
-499
| Closed | -$322K | – | 493 |
|
|
2021
Q2 | $322K | Sell |
499
-7,526
| -94% | -$4.86M | 0.02% | 388 |
|
|
2021
Q1 | $4.58M | Buy |
+8,025
| New | +$4.58M | 0.26% | 149 |
|